[Purpose] The purpose of this study was to conduct a systematic review of the available evidence on sleep disorders in patients with end stage renal disease (ESRD) undergoing hemodialysis (HD). [Subjects and Methods] Two independent reviewers performed a computer-assisted search of the MEDLINE, SciELO, LILACS, and BIREME Virtual Health Library medical databases from their inception to November 2015.
INTRODUCTION
Currently, chronic kidney disease (CKD) is one of the most serious public health problems. Some recent epidemiological studies have suggested that approximately one million people with end stage renal disease (ESRD) undergo replacement therapy worldwide. The increased prevalence of CKD in the developed and developing countries threatens to become a global epidemic, as exemplified by the increased number of cases of diabetes mellitus and the increased life expectancy of the population 1) . CKD severely affects patients' health, lifestyle and wellbeing, compromising their quality of life 2) . According Ponngeon et al., CKD patients had "sedentary" and "inactive" levels of physical activity on dialysis and non-dialysis days, respectively 3) . Silva and Marinho observed that the level of physical activity of most patients ESRD undergoing hemodialysis is poor and that most do not perform exercise regularly 4) . The most common comorbidities observed in patients with CKD are diabetes mellitus type 2 1) , dyslipidemia, coronary heart disease, heart failure 5, 6) , hypertension 7, 8) , respiratory disorders 8, 9) , stress 10) , depression [10] [11] [12] , anxiety 13) , and obstructive sleep apnea (OSA) 14) .
OSA is a major medical problem, estimated to affect up to 15-30% of male adults and up to 5-15% of female adults 15, 16) . It is characterized by repetitive obstructions of the upper airway during sleep, frequently causing oxygen desaturation. This induces frequent awakenings (arousals), resulting in fragmented sleep and excessive daytime sleepiness.
In Brazil, according to a recent epidemiological study conducted in São Paulo, an OSA prevalence of 24.8% in men and 9.6% in women was observed, based on an apnea-hypopnea index (AHI)≥15 events/h; for an AHI≥5 events/h, this prevalence increased to 40% in men and 26% in women 17) . In a recent study involving 2,121 individuals conducted in the city of Lausanne in Switzerland, a prevalence of 50% in men and 23% in women was observed, based on an AHI≥15 events/ h 18) . In another study conducted by Oliveira et al., patients with neuromuscular disorders such as myasthenia gravis were observed to have a poor quality of sleep, excessive daytime sleepiness, presence of restless syndrome, and a high incidence of sleep-disordered breathing (SDB) 19) .
The prevalence of sleep disorders among patients with CKD is 40-80%, which is higher than that among the general population. Among these sleep disorders, the presence of periodic leg movements during sleep and OSA has been highlighted 20) .
The high prevalence (50%) of SDB in patients undergoing hemodialysis (HD) can be attributed to compromised upper airway stability (extracellular fluid volume overload) [21] [22] [23] , ventilatory control instability (altered central and peripheral chemosensitivity), and reduced upper airway muscle tone (uremia) [24] [25] [26] [27] [28] . Risk factors of SDB in the general population, such as older age, male gender, obesity, smoking, increased neck circumference, and diabetes, are also prevalent in the CKD population 29) .
SDB has been associated with increased cardiovascular risk, and may contribute to the morbidity and mortality of patients with advanced (stages 4 to 5) CKD or those undergoing HD 30) .
Although numerous studies have shown that a substantial proportion of patients undergoing HD have sleep apnea, these studies were limited by the following factors: very small sample sizes 27, [31] [32] [33] [34] ; the use of partial channel polysomnography (PSG) [34] [35] [36] ; the study of populations with limited generalizability to patients undergoing HD 37) ; a selected subpopulation of patients undergoing dialysis, without sleep symptoms 38) ; or study samples that were largely composed of symptomatic patients 26, 31, 39) . Hence, a better understanding of the prevalence and risk factors of SDB in CKD patients undergoing HD is critical. Therefore, a systematic review that can demonstrate the status of the knowledge is justified. This knowledge may enable health professionals, especially physiotherapists, to devise new strategies to reduce morbidity and mortality and improve the quality of life of CKD patients. The present study aimed to provide a thorough overview of the literature regarding the occurrence of sleep disorders in patients with ESRD undergoing HD.
SUBJECTS AND METHODS
Two independent reviewers performed a computer-assisted search of the MEDLINE, LILACS, and SciELO Virtual Health Library medical databases from their inception to November 2015. A combination of the following Medical Subject Headings (MeSH) were used in the search ("sleep" OR "sleep disorders" OR "obstructive sleep apnea") AND ("kidney dialysis" OR "hemodialysis" OR "dialysis").
The first stage of the search identified articles according to the title, abstract, and key words. In the second stage, the contents of the manuscripts were evaluated. Articles that involved patients >18 years old, having ESRD and undergoing HD, and that used overnight standard PSG for the diagnosis of sleep disorders, were included in the final analysis. This systematic review followed the criteria outlined in the PRISMA declaration 40) .
RESULTS
One thousand one hundred twenty-six articles were identified that met the inclusion criteria. A total of 796 articles were excluded because they were not in English, the patients did not undergo HD, or the studies were not cross-sectional or clinical trials. After an evaluation of the full text, 312 studies were excluded, either because PSG was not performed or they were duplicated. The remaining 18 studies, comprising 8 clinical trials and 10 cross-sectional studies, were included for further examination (Fig. 1) . The results and outcomes of all included studies are summarized in Tables 1 and 2 and are discussed below. Thus, a detailed analysis of 18 articles that used overnight PSG, which is considered the gold standard method for the diagnosis of sleep disorders, was conducted.
DISCUSSION
The aim of this study was to conduct a systematic review of studies showing the presence of sleep disorders in patients with ESRD undergoing HD.
The presence of sleep disorders, including SDB, Periodic Limb Movement Disorder (PLMD) and/or Restless Legs Syndrome (RLS), which compromise the quality of life and increase the morbidity and mortality rates of patients with CKD, has been documented in the literature [50] [51] [52] [53] . Seventy percent of ESRD patients are believed to have some form of SDB 26, 39) . RLS is a common and extremely distressing problem experienced by many patients undergoing HD. It is a neurological condition characterized by an irresistible urge to move the legs and occurs more frequently during inactivity and at night 54, 55) .
The prevalence of RLS in patients who are under treatment with HD varies across studies performed in broad geographical regions (6.6-68%), and recent studies using the International RLS Study Group criteria have suggested a prevalence rate of 33% in ESRD patients, which is greater than that in the general population 56) .
Sleep fragmentation and sleep deprivation caused by RLS may contribute to cardiovascular complications and infections, often with poor prognosis in patients undergoing HD. According to the literature, patients undergoing HD have a poorer quality of sleep compared to the normal population. The presence of RLS and associated sleep disorders, such as daytime sleepiness, insomnia, and poor sleep quality, should be considered a problem that further impairs the quality of life of patients. Studies have demonstrated that 40-80% of ESRD patients undergoing HD suffer from poor sleep quality associated with a poor quality of life 57, 58) . Sleep disorders are usually associated with physical, behavioral, and psychological disorders that predispose to cognitive impairment, decline in social performance and interpersonal interactions, and depression 59) . SDB is very common among patients with CKD, especially those undergoing HD 36, 60) . Some studies have suggested OSA has a prevalence of 50-60% in ESRD patients 12, 61) . Depending on the methodology applied, approximately 50-80% of CKD patients have some form of SDB 26, 39) . OSA is 4 to 10 times more prevalent among CKD patients than in the general population 22, 49) . A more recent study conducted by Nicholls et al. involving 254 CKD patients showed a significant increase in the occurrence of SDB (predominantly OSA) which was related to impairment of renal function, with a prevalence of 57% 62) .
This study utilized only studies performed using PSG, considered the gold standard for the diagnosis of sleep disorders. Despite the high prevalence of sleep disorders in the CKD population, there is limited scientific research on the topic, as evidenced by only as shown by 18 studies (10 cross-sectional studies and 8 controlled clinical trials) having been retrieved in this review. This is perhaps explained by the high cost of PSG examination, or by a lack of knowledge about the presence of sleep disorders in CKD population.
Other more viable diagnostic methods, such as pulse oximetry and specific validated sleep questionnaires, could be used as screening tools for the presence of SDB, aiding in the early diagnosis and choice of appropriate treatment with noninvasive ventilatory support.
Epidemiological studies have shown a strong and intrinsic relationship between CKD and OSA. ESRD contributes to the emergence and/or development of OSA due to factors such as metabolic acidosis, compromised sensitivity of chemoreceptors, uremic toxins, generalized muscle weakness, particularly of the dilator muscles of the pharynx, and narrowing of the upper airway due to fluid accumulation in the interdialytic period. It is known that OSA induces CKD due to increased blood pressure, oxidative stress, and repetitive hypoxia. Therefore, OSA is a major risk factor for CKD.
This systematic review verified the status of knowledge regarding the prevalence of sleep disorders in ESRD patients Forty-one patients presented with SA; 27
had SA with symptoms such as daytime somnolence and snoring. There is a high prevalence of SA in HD patients.
Good management of these factors might improve SA in HD patients.
Jung et al. Severe SDB and excessive daytime sleepiness are common among advanced CKD and HD patients.
ESRD: end-stage renal disease; HD: hemodialysis; CKD: chronic kidney disease; PLM: periodic leg movement; SDB: sleep disordered breathing; PSG: overnight standard polysomnography; ESS: Epworth sleepiness scale; SA: sleep apnea; RLS: restless legs syndrome; TST: total sleep time undergoing HD. According to the studies analyzed, a high prevalence of PLMD, RLS, and OSA affecting the quality of sleep was observed, which in turn undermined the quality of life of these patients, leading to increased morbidity and mortality. Thus, it is very important for healthcare professionals to recognize the signs and symptoms of sleep disorders in CKD patient population, both for accurate diagnosis and an appropriate therapeutic approach. For physical therapists, it is extremely important to identify SDB, particularly OSA, so they can institute treatment with continuous positive airway pressure.
